Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« More On Cancer Drug Shortages | Main | Drug Research Areas You Wish You'd Never Heard Of »

August 9, 2011

What An Offer

Email This Entry

Posted by Derek

The glamorous side of blogging is that you get chances like this, delivered right to your e-mail queue:

". . .I am working with a couple of small-cap biotech companies who have good fundamental technologies, but are not on the radar screen of a lot of investors. We are looking for some influential bloggers to put some spotlight on these companies, so more people can be exposed to the value proposition and opportunities available. In the past we have worked with some bloggers who have written both paid as well as unpaid articles on these companies. I would like to explore your interest and to discuss this further. . .

I explained to this person just what my level of interest was, in terms that I don't think were misinterpretable, and pointed out that if their operation was not, in fact, a pump-and-dump penny stock scheme, then they should take more care not to make it sound exactly like one. But I thought I would at least get some use of of this sleazy offer by getting a few things on the record.

I write paid columns for Contract Pharma and Chemistry World, and I occasionally do paid pieces for other (respectable!) outlets. But in none of those do I tout stocks, companies, or products. As for the material on this blog, it's produced for free, which (by no coincidence) is what I charge for reading it. The only money that changes hands around here is if someone buys something through an Amazon link, and I try to keep those down to things that people could actually find useful and relevant - no links to plasma TV sales, for example, although if you want to buy one through Amazon, please do feel free.

And of course, I stay away from anything that might involve (or be thought to involve) material information concerning my place of work. But there are no commercial considerations involved in my choice of topics or my expressed opinions on them. If I have a stock position in a company - a rare event, these days, since my kids and my mortgage have seen to it that I don't have a vast fund of free-floating investment capital - then I say so. (A careful look though the archives would show that depending on me for investment advice is not necessarily a winning plan, although it would at least be full of excitement).

So there you have it. No pay-for-play around here. But if you across someone going on about what a great thing this tiny biotech you've never heard of is, well, exercise the usual amount of caution.

Comments (10) + TrackBacks (0) | Category: Blog Housekeeping | The Dark Side


COMMENTS

1. Myma on August 9, 2011 9:29 AM writes...

And with that said, I think it is about time for another "Things I won't work with" column. Please, pretty please?
I'll even take a "How not to do it" post.

Permalink to Comment

2. Still Scared of Dinosaurs on August 9, 2011 9:37 AM writes...

Whenever someone touts the efficient market hypothesis just remind them that penny stock pump-and-dump schemes still appear to work. At least I assume they do given the number of times I click on "what the heck" links and find sidebar ads for penny stocks.

Everybody to the boiler room!

Permalink to Comment

3. Derek Lowe on August 9, 2011 9:48 AM writes...

Myma, I know what you mean! Comic relief is in short supply these days, but I'll see what I can do. . .

Permalink to Comment

4. Sili on August 9, 2011 10:06 AM writes...

Actually, if I had a coupla millions to spare, I'd try to hire you to run a drug company for me.

I'll get back to you when I'm done watching my meagre savings haemorrhage.

Permalink to Comment

5. Anonymous on August 9, 2011 10:36 AM writes...

All this talk of advertising is giving me a headache...normally I'd have to have 8 Tylenol, but with just 2 Aleve, I get great pain relief all day!!

Permalink to Comment

6. Anonymous on August 9, 2011 11:27 AM writes...

@ Sili - As you can tell from the post, Derek is far too ethical to run a pharmaceutical company.

Permalink to Comment

7. Terry on August 9, 2011 12:16 PM writes...

It is a good idea to write blog to earn money!
From the ethical point you can just mark each of the posters of the small start up companies as advertisement, thus you can give the exact information to the readers and earn money as well.
I wrote stock analysis posters of chemical and pharmaceutical companies in china sometime, no one seems like to offer me money to do it!

Permalink to Comment

8. Sili on August 9, 2011 3:08 PM writes...

@ Sili - As you can tell from the post, Derek is far too ethical to run a pharmaceutical company.
Hey! I never said he had to turn a profit!

Oh ... nevermind ...

Permalink to Comment

9. DCRogers on August 9, 2011 7:37 PM writes...

@2

"Whenever someone touts the efficient market hypothesis just remind them that penny stock pump-and-dump schemes still appear to work."

The only question is, is the wasted money derived mostly from the sucker buying this useless service, or do enough volunteers lacking-in-clues line up to click the link and share in the fleecing?

Permalink to Comment

10. NHR_GUY on August 9, 2011 9:19 PM writes...

Way to go Big-D, keepin' it real. Not sellin' out to da man. Way to go homie

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Scripps Update
What If Drug Patents Were Written Like Software Patents?
Stem Cells: The Center of "Right to Try"
Speaking of Polyphenols. . .
Dark Biology And Small Molecules
How Polyphenols Work, Perhaps?
More On Automated Medicinal Chemistry
Scripps Merging With USC?